Loading provider…
Loading provider…
Ophthalmology Physician in Loma Linda, CA
NPI: 1336112812Primary Employer
Faculty Physicians and Surgeons of Llusm
lluh.org
HQ Phone
Get MD Kakarla's Phone Numberphone_androidMobile
Get MD Kakarla's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License
CA State Medical License
SC State Medical License
1994 - 2027
CA State Medical License
2017 - 2026
FL State Medical License
1997 - 2026
NY State Medical License
1989 - 2026
PA State Medical License
2017 - 2026
TX State Medical License
1992 - 2026

American Board of Ophthalmology
Ophthalmology
Post Graduate Institute of Medical Education & Research
1980 - 1983
1980 - 1983
University of South Carolina
Molecular Biology
1996 - 2000
Webster University
Business Administration
1997 - 1999
University of Texas Southwestern Medical Center
Fellowship • 1992 - 1994
1992 - 1994
New York Presbyterian Hospital (Columbia Campus)
Residency • Ophthalmology
1989 - 1992
Royal College of Surgeons of Canada
1991 - 1991
1991 - 1991
New York Presbyterian Hospital (Cornell Campus)
Internship • Surgery
1988 - 1989
Royal College of Surgeons
1984 - 1984
1984 - 1984
Guntur Medical College NTR
Medical School
Until 1979
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 92134Diagnostic imaging of retina | 419 | 875 |
| 2 | 92014Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | 373 | 731 |
| 3 | 92235Imaging of blood vessels in back of eye using fluorescein dye | 108 | 112 |
| 4 | 92250Photography of the retina | 82 | 134 |
| 5 | 99214Established patient office or other outpatient visit, 30-39 minutes | 76 | 76 |
Authors: Chalam, Kakarla V, Shah, Gaurav Y, Shah, Vinay A
Journal: Am J Ophthalmol
Bevacizumab therapy normalizes the pathological intraocular environment beyond neutralizing VEGF.
Authors: Sharma, Rajesh K, Rogojina, Anna T, Chalam, K V
Journal: Mol Vis
Publication Date: 2010-10-27